BiomX to Present at Upcoming September Investor Conferences

Rhea-AI Summary

BiomX Inc. (NYSE American: PHGE), a clinical-stage microbiome company, announced that CEO Jonathan Solomon will present at three virtual investor events in September 2021. The events include the H.C. Wainwright 23rd Annual Global Investments Conference on September 13, the Oppenheimer Virtual Fall Healthcare Life Science & MedTech Summit on September 20, and the Cantor 2021 Virtual Global Healthcare Conference on September 30. Live webcasts will be available on BiomX's website, and archived materials will be accessible post-event.

BRANFORD, Conn. and NESS ZIONA, Israel, Sept. 02, 2021 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced Jonathan Solomon, Chief Executive Officer, will be presenting at three upcoming virtual investor events in September.

Presentation Details:

Event: H.C. Wainwright 23rd Annual Global Investments Conference
Date: Monday, Sept. 13, 2021
Time: 7:00 a.m. EDT

Event: Oppenheimer Virtual Fall Healthcare Life Science & MedTech Summit
Date: Monday, Sept. 20, 2021
Time: 1:15 – 1:55 p.m. EDT

Event: Cantor 2021 Virtual Global Healthcare Conference
Date: Thursday, Sept. 30, 2021
Time: 11:20 a.m. EDT

Live webcasts of the three presentations will be accessible through the Investors section of the Company’s website at https://ir.biomx.com/news-events/ir-calendar. Following the events, the webcasts will be archived on the BiomX website.

About BiomX

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Additional information is available at www.biomx.com, the content of which does not form a part of this press release.

BiomX, Inc.
Assaf Oron
Chief Business Officer
+972 (54) 222-8901
assafo@biomx.com

Investors:
John Mullaly
LifeSci Advisors, LLC
(617) 429-3548
jmullaly@lifesciadvisors.com

Source: BiomX Inc

FAQ

What is BiomX's stock symbol?

BiomX's stock symbol is PHGE.

When will Jonathan Solomon present at the H.C. Wainwright conference?

Jonathan Solomon will present at the H.C. Wainwright conference on September 13, 2021, at 7:00 a.m. EDT.

What are the dates for the upcoming investor events for BiomX?

BiomX will participate in three events: September 13, September 20, and September 30, 2021.

How can I access the live webcasts of BiomX's presentations?

Live webcasts for BiomX's presentations will be available on their website under the Investors section.

What types of therapies does BiomX focus on?

BiomX focuses on natural and engineered phage therapies targeting pathogenic bacteria related to skin appearance and chronic diseases.